How to buy TC BioPharm stock in Canada

TC BioPharm is a biotechnology business based in the US. TC BioPharm shares (TCBP) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $0.37 – a decrease of 8.77% over the previous week. TC BioPharm employs 41 staff and has a trailing 12-month revenue of around $2.9 million.

Our top picks for where to buy TC BioPharm stock

Buy TC BioPharm stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

TC BioPharm stock price (NASDAQ: TCBP)

Use our graph to track the performance of TCBP stocks over time.

TC BioPharm stocks at a glance

• Key figures

Information last updated 2025-01-12.

Latest market close	$0.37
52-week range	$0.35 - $19.68
50-day moving average more info button	$3.86
200-day moving average more info button	$8.94
Wall St. target price	$140.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-192.95

Is it a good time to buy TC BioPharm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

TC BioPharm price performance over time

Historical closes compared with the close of $0.379 from 2025-01-17

1 week (2025-01-14)	-17.57%
1 month (2024-12-20)	-42.58%
3 months (2024-10-22)	-85.42%
6 months (2024-07-19)	-55.61%

1 year (2024-01-19)	-83.80%
2 years (2023-01-20)	-99.95%
3 years (2022-01-18)	N/A
5 years (2020-01-18)	N/A

TC BioPharm financials

Revenue TTM	$2.9 million
Gross profit TTM	$3.8 million
Return on assets TTM	-108.92%
Return on equity TTM	-1217.48%
Profit margin	0%
Book value	$3.38
Market Capitalization more info button	$360,373

TTM: trailing 12 months

TC BioPharm stock dividends

We're not expecting TC BioPharm to pay a dividend over the next 12 months.

Have TC BioPharm's stocks ever split?

TC BioPharm's stocks were split on a 1:10 basis on 4 August 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TC BioPharm stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for TC BioPharm stocks, which in turn could have impacted TC BioPharm's stock price.

TC BioPharm stock price volatility

Over the last 12 months, TC BioPharm's stocks have ranged in value from as little as $0.3487 up to $19.68. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while TC BioPharm's is 0.249. This would suggest that TC BioPharm's stocks are less volatile than average (for this exchange).

TC BioPharm overview

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of TC BioPharm is owned by insiders or institutions?
Currently 0.006% of TC BioPharm stocks are held by insiders and 1.763% by institutions. How many people work for TC BioPharm?
Latest data suggests 41 work at TC BioPharm. When does the fiscal year end for TC BioPharm?
TC BioPharm's fiscal year ends in December. Where is TC BioPharm based?
TC BioPharm's address is: Maxim 1, Motherwell, United Kingdom, ML1 4WR What is TC BioPharm's ISIN number?
TC BioPharm's international securities identification number is: US87807D1037

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.